| Year |
Citation |
Score |
| 2023 |
Imamichi T, Chen Q, Sowrirajan B, Yang J, Laverdure S, Marquez M, Mele AR, Watkins C, Adelsberger JW, Higgins J, Sui H. Interleukin-27-induced HIV-resistant dendritic cells suppress reveres transcription following virus entry in an SPTBN1, autophagy, and YB-1 independent manner. Plos One. 18: e0287829. PMID 37910521 DOI: 10.1371/journal.pone.0287829 |
0.582 |
|
| 2023 |
Imamichi T, Chen Q, Sowrirajan B, Yang J, Laverdure S, Mele AR, Watkins C, Adelsberger JW, Higgins J, Sui H. Interleukin-27-induced HIV-resistant dendritic cells suppress reveres transcription following virus entry in an SPTBN1, Autophagy, and YB-1 independent manner. Biorxiv : the Preprint Server For Biology. PMID 37546823 DOI: 10.1101/2023.06.12.544550 |
0.582 |
|
| 2021 |
Imamichi T, Bernbaum JG, Laverdure S, Yang J, Chen Q, Highbarger H, Hao M, Sui H, Dewar R, Chang W, Lane HC. Natural Occurring Polymorphisms in HIV-1 Integrase and RNase H Regulate Viral Release and Autoprocessing. Journal of Virology. JVI0132321. PMID 34523971 DOI: 10.1128/JVI.01323-21 |
0.432 |
|
| 2021 |
Imamichi T, Goswami S, Hu X, Laverdure S, Yang J, Qiu J, Chen Q, Sherman BT, Chang W. MicroRNA Profiles in Monocyte-Derived Macrophages Generated by Interleukin-27 and Human Serum: Identification of a Novel HIV-Inhibiting and Autophagy-Inducing MicroRNA. International Journal of Molecular Sciences. 22. PMID 33525571 DOI: 10.3390/ijms22031290 |
0.319 |
|
| 2016 |
Laverdure S, Polakowski N, Hoang K, Lemasson I. Permissive Sense and Antisense Transcription from the 5' and 3' Long Terminal Repeats of Human T-Cell Leukemia Virus Type 1. Journal of Virology. 90: 3600-10. PMID 26792732 DOI: 10.1128/Jvi.02634-15 |
0.62 |
|
| 2014 |
Polakowski N, Terol M, Hoang K, Nash I, Laverdure S, Gazon H, Belrose G, Mesnard JM, Césaire R, Péloponèse JM, Lemasson I. HBZ stimulates brain-derived neurotrophic factor/TrkB autocrine/paracrine signaling to promote survival of human T-cell leukemia virus type 1-Infected T cells. Journal of Virology. 88: 13482-94. PMID 25210182 DOI: 10.1128/Jvi.02285-14 |
0.637 |
|
| 2014 |
Arpin-André C, Laverdure S, Barbeau B, Gross A, Mesnard JM. Construction of a reporter vector for analysis of bidirectional transcriptional activity of retrovirus LTR. Plasmid. 74: 45-51. PMID 24971710 DOI: 10.1016/J.Plasmid.2014.06.001 |
0.66 |
|
| 2012 |
Laverdure S, Gross A, Arpin-André C, Clerc I, Beaumelle B, Barbeau B, Mesnard JM. HIV-1 antisense transcription is preferentially activated in primary monocyte-derived cells. Journal of Virology. 86: 13785-9. PMID 23035216 DOI: 10.1128/Jvi.01723-12 |
0.59 |
|
| 2011 |
Clerc I, Laverdure S, Torresilla C, Landry S, Borel S, Vargas A, Arpin-André C, Gay B, Briant L, Gross A, Barbeau B, Mesnard JM. Polarized expression of the membrane ASP protein derived from HIV-1 antisense transcription in T cells. Retrovirology. 8: 74. PMID 21929758 DOI: 10.1186/1742-4690-8-74 |
0.584 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2019 |
Hu X, Goswami S, Qiu J, Chen Q, Laverdure S, Sherman BT, Imamichi T. Profiles of Long Non-Coding RNAs and mRNA Expression in Human Macrophages Regulated by Interleukin-27. International Journal of Molecular Sciences. 20. PMID 31835347 DOI: 10.3390/ijms20246207 |
0.284 |
|
| 2021 |
Laverdure S, Wang Z, Yang J, Yamamoto T, Thomas T, Sato T, Nagashima K, Imamichi T. Interleukin-27 promotes autophagy in human serum-induced primary macrophages via an mTOR- and LC3-independent pathway. Scientific Reports. 11: 14898. PMID 34290273 DOI: 10.1038/s41598-021-94061-3 |
0.258 |
|
| 2021 |
Hu X, Goswami S, Qiu J, Chen Q, Laverdure S, Sherman BT, Imamichi T. Correction: Hu et al. Profiles of Long Non-Coding RNAs and mRNA Expression in Human Macrophages Regulated by Interleukin-27. 2019, , 6207. International Journal of Molecular Sciences. 22. PMID 34066303 DOI: 10.3390/ijms22105129 |
0.203 |
|
| 2018 |
Rizk F, Laverdure S, d'Alençon E, Bossin H, Dupressoir T. Linear 1 sequences drive random integration of a reporter gene in transfected cells. Peerj. 6: e4860. PMID 29868273 DOI: 10.7717/peerj.4860 |
0.199 |
|
| 2023 |
Huapaya JA, Higgins J, Kanth S, Demirkale C, Gairhe S, Aboye EA, Regenold D, Sahagun SJ, Pastor G, Swaim D, Dewar R, Rehman T, Highbarger HC, Lallemand P, Laverdure S, et al. Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections. The Journal of Infectious Diseases. PMID 36801946 DOI: 10.1093/infdis/jiad045 |
0.174 |
|
| 2022 |
Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM, Rogers R, Shehadeh F, Kaczynski M, Mylona EK, Syrigos KN, ... ... Laverdure S, et al. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial. Annals of Internal Medicine. 175: 1266-1274. PMID 35939810 DOI: 10.7326/M22-1503 |
0.164 |
|
| 2023 |
Dabitao D, Shaw-Saliba K, Konate DS, Highbarger HC, Lallemand P, Sanogo I, Rehman T, Wague M, Coulibaly N, Kone B, Baya B, Diakite SAS, Samake S, Akpa E, Tounkara M, ... Laverdure S, et al. Clinical evaluation of commercial SARS-CoV-2 serological assays in a malaria endemic setting. Journal of Immunological Methods. 113488. PMID 37179012 DOI: 10.1016/j.jim.2023.113488 |
0.113 |
|
| 2024 |
Aggarwal NR, Nordwall J, Braun DL, Chung L, Coslet J, Der T, Eriobu N, Ginde AA, Hayanga AJ, Highbarger H, Holodniy M, Horcajada JP, Jain MK, Kim K, Laverdure S, et al. Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 38376212 DOI: 10.1093/cid/ciad780 |
0.085 |
|
| 2023 |
Jensen TO, Grandits GA, Jain MK, Murray TA, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, ... ... Laverdure S, et al. Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19. The Journal of Infectious Diseases. PMID 37948759 DOI: 10.1093/infdis/jiad446 |
0.046 |
|
| 2022 |
Sasson J, Donlan AN, Ma JZ, Haughey HM, Coleman R, Nayak U, Mathers AJ, Laverdure S, Dewar R, Jackson PEH, Heysell SK, Sturek JM, Petri WA. Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial. Medrxiv : the Preprint Server For Health Sciences. PMID 35411349 DOI: 10.1101/2022.03.30.22273194 |
0.031 |
|
| 2022 |
Sasson J, Donlan AN, Ma JZ, Haughey HM, Coleman R, Nayak U, Mathers AJ, Laverdure S, Dewar R, Jackson PEH, Heysell SK, Sturek JM, Petri WA. Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial. Open Forum Infectious Diseases. 9: ofac343. PMID 35959207 DOI: 10.1093/ofid/ofac343 |
0.027 |
|
| 2022 |
Sereti I, Shaw-Saliba K, Dodd LE, Dewar RL, Laverdure S, Brown S, Mbaya OT, Muyembe Tamfum JJ, Mblala-Kingebeni P, Sow Y, Akpa E, Haidara MC, Fouth Tchos K, Beavogui AH, Neal A, et al. Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE). Plos One. 17: e0273914. PMID 36107966 DOI: 10.1371/journal.pone.0273914 |
0.01 |
|
| Hide low-probability matches. |